WEED Archives - BioTuesdays

Executive Moves

Canopy Growth’s medical division names Dr. Marcel Bonn-Miller as global clinical scientific director

Spectrum Therapeutics, the medical division of Canopy Growth (TSX:WEED; NYSE:CGC) appointed Dr. Marcel Bonn-Miller as global clinical scientific director.

June 5, 2019

Developments

Canopy Growth acquires skincare and well-being company, This Works

Canopy Growth (TSX:WEED; NYSE: CGC) acquired This Works in an all-cash transaction for £43 million. British-based This Works offers a range of high-quality natural skincare and sleep solution products, including deep...

May 22, 2019

Executive Moves

Canopy Growth names Mike Lee as acting CFO

Canopy Growth (TSX:WEED; NYSE:CGC) appointed Mike Lee as acting CFO, effective June 1, and subject to Health Canada security clearance required for all officers and directors of the company.

May 21, 2019

Developments

Canopy Growth unveils new cannabis commercial medical and research unit, Spectrum Therapeutics

Canopy Growth (TSX:WEED; NYSE:CGC) unveiled Spectrum Therapeutics, a new global brand that will encompass all of the company’s ongoing commercial medical and clinical research operations. These include Spectrum...

May 7, 2019

Developments

Canopy Growth acquires Germany’s C3 Cannabinoid Compound Co. for €225.9 million

Canopy Growth (TSX:WEED; NYSE:CGC) acquired C3 Cannabinoid Compound Co. for €225.9 million (CDN $342.9-million) in a transformative deal that furthers Canopy’s expansion in Europe with prescription medicines. The...

May 2, 2019

Developments

Canopy Growth secures site for NY state hemp industrial park

Canopy Growth (TSX:WEED; NYSE:CGC) secured a 308,000-square-foot facility on a 48-acre property in Kirkwood, NY for its hemp industrial park in the southern tier region of New York State. The vision for the property is...

April 29, 2019

Developments

Canopy Growth acquires Spanish licensed cannabis producer

Canopy Growth (TSX:WEED; NYSE:CGC) completed an all-cash acquisition of Spain-based licensed cannabis producer, Cáñamo y Fibras Naturales, (Cafina). The acquisition lays the foundation for Canopy to expand its European...

April 16, 2019

Developments

Canopy Growth receives NY hemp license; plans to establish U.S. commercial operations

Canopy Growth (TSX:WEED) (NYSE:CGC) received a licence from New York State to process and produce hemp and will establish large-scale hemp extraction and product manufacturing in the state. Subject to board approval of...

January 14, 2019

Feature

Canopy Health to expand clinical mandate with Constellation Brands investment

Canopy Health Innovations, the research subsidiary of Canopy Growth (TSX:WEED; NYSE:CGC) that focuses on the development of therapeutic and natural health cannabis products, will get a big boost from a blockbuster $5...

December 11, 2018

Feature

Canopy Health aims to evolve medical cannabis as a natural drug product and disrupt pharma market

By Len Zehr As president and CEO of newly formed Canopy Health Innovations, a spin off of Canopy Group (TSX:WEED), a world leading diversified cannabis company, Marc Wayne is a pioneer of the medical cannabis sector. He...

June 20, 2017

Tag - WEED

Canopy Growth’s medical division names Dr. Marcel Bonn-Miller as global clinical scientific director

Canopy Growth acquires skincare and well-being company, This Works

Canopy Growth names Mike Lee as acting CFO

Canopy Growth unveils new cannabis commercial medical and research unit, Spectrum Therapeutics

Canopy Growth acquires Germany’s C3 Cannabinoid Compound Co. for €225.9 million

Canopy Growth secures site for NY state hemp industrial park

Canopy Growth acquires Spanish licensed cannabis producer

Canopy Growth receives NY hemp license; plans to establish U.S. commercial operations

Canopy Health to expand clinical mandate with Constellation Brands investment

Canopy Health aims to evolve medical cannabis as a natural drug product and disrupt pharma market

General

More